Skip to content

Prospective Study on Asthma Control

Cross-sectional and Prospective Observational Study Aimed to Assess the Prevalence of Uncontrolled and Partially Controlled Asthmatics in Italy and the Prevalence of Uncontrolled/Partially Controlled Patients Achieved Asthma Control After 12 Months

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01110460
Acronym
PRISMA
Enrollment
2875
Registered
2010-04-26
Start date
2009-01-31
Completion date
2010-11-30
Last updated
2025-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

Accordingly, the new update of the Global Initiative for Asthma (GINA) guidelines 2006 is based on the control of the disease and attempts to quantify and graduate the level of control by using a classification of asthmatic subjects into controlled,partly controlled and uncontrolled groups. Achieving and maintaining optimal asthma control is a major goal of asthma management. Although the results of clinical trials advocate that asthma control can be reached in most patients, there is evidence that many subjects with asthma have poorly controlled disease and that there is a significant gap between the treatment goals and the current level of asthma control achieved in the general population. The aim of this study is to assess the prevalence of uncontrolled and partly controlled asthma in Italy using a patient-based tool such as Asthma Control Test.

Interventions

None listed

Sponsors

Medidata Solutions
CollaboratorINDUSTRY
Chiesi Farmaceutici S.p.A.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Written informed consent obtained * Male or female patients with asthma diagnosis (at least 6 months) * ability to understand and fill in questionaires

Exclusion criteria

* Patients included in a clinical trial within the last 12 weeks * Patients with serious illnesses * Pregnant women

Design outcomes

Primary

MeasureTime frame
Asthma control test score3 months

Secondary

MeasureTime frame
EuroQoL test score3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026